Comparison of Thrombocytopenia and Splenomegaly in Locally Advanced Rectal Cancer Patients Receiving Total Neoadjuvant Therapy With and Without Immunotherapy

医学 内科学 胃肠病学 结直肠癌 化疗 放射治疗 队列 养生 多元分析 脾切除术 封锁 血小板 回顾性队列研究 外科 环磷酰胺 白细胞减少症 肿瘤科 新辅助治疗 癌症 比例危险模型 脾脏 毒性 肛癌 放化疗 队列研究 免疫疗法 化疗方案 氟尿嘧啶 并发症
作者
Shuwen Li,Mingxu Yan,Qiong Ma,Yiqun Sun,Zhen Zhang,Lijun Shen,Jufeng Wan,Hui Zhang,Ruiyan Wu,Fan Xia,Yaqi Wang
出处
期刊:Cancer Medicine [Wiley]
卷期号:15 (8): e72183-e72183
标识
DOI:10.1002/cam4.72183
摘要

ABSTRACT Background Thrombocytopenia is a common toxicity of oxaliplatin‐based chemotherapy and may be linked to hepatic sinusoidal obstruction and splenic enlargement. In the TORCH trial, adding PD‐1 blockade to an oxaliplatin‐containing total neoadjuvant therapy (TNT) regimen improved tumor response in patients with locally advanced rectal cancer (LARC), but thrombocytopenia appeared more frequent and more severe. Here, we evaluated whether adding PD‐1 blockade to TNT increased thrombocytopenia risk and explored its association with hepatic injury and splenomegaly. Methods We retrospectively reviewed 181 LARC patients treated at Fudan University Shanghai Cancer Center. The cohort included 44 patients who received long‐course chemoradiotherapy (LCRT) followed by oxaliplatin‐containing chemotherapy (Ox‐TNT), 41 who received LCRT followed by irinotecan‐based chemotherapy (Iri‐TNT), and 96 who received short‐course radiotherapy plus six cycles of CAPOX and toripalimab (iTNT). We collected serial blood test results and measured liver and spleen volumes before and after treatment. Thrombocytopenia was graded according to CTCAE v5.0. Results Among 181 patients, thrombocytopenia occurred in 118 (65.2%), and splenomegaly in 69 (38.1%). Both events were most frequent in iTNT group, with incidences of 83.3% and 61.5%, respectively. Rates were lower in Ox‐based TNT group (50.0% and 13.6%) and in Iri‐based TNT group (39.0% and 9.8%), respectively. Platelet count showed an inverse correlation with both increased AST level ( p < 0.001) and splenic volume ( p < 0.001). In multivariate analysis, iTNT ( p = 0.002), splenomegaly ( p = 0.003), and older age ( p = 0.004) were independently associated with G2‐4 thrombocytopenia. Factors that independently predicted splenomegaly included iTNT ( p < 0.001), direct bilirubin ( p = 0.031), hepatomegaly ( p = 0.032), and AST ( p = 0.032). In the iTNT group, splenomegaly ( p = 0.009) and older age ( p = 0.033) remained associated with G2‐4 thrombocytopenia. Lower CD8 + CD28 + T cells and higher NK cells were associated with thrombocytopenia. Conclusions PD‐1 blockade added to TNT was associated with more severe thrombocytopenia than conventional TNT in LARC patients, possibly through greater hepatic injury and splenomegaly.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
空城完成签到 ,获得积分20
1秒前
1秒前
ladywerwer完成签到,获得积分10
2秒前
2秒前
2秒前
wspqbs发布了新的文献求助30
4秒前
4秒前
风中巧凡完成签到,获得积分10
5秒前
bqys发布了新的文献求助10
5秒前
jean完成签到,获得积分10
6秒前
哇啦发布了新的文献求助10
6秒前
7秒前
研友_VZG7GZ的应助被O基米德采纳,获得10
7秒前
笑点低薯片完成签到,获得积分10
10秒前
小马甲的应助被调皮钧采纳,获得10
10秒前
雅2018完成签到 ,获得积分10
11秒前
11秒前
能干发卡完成签到,获得积分10
11秒前
zqq完成签到,获得积分10
11秒前
郗超悦完成签到,获得积分10
12秒前
SciGPT的应助被学术小白采纳,获得10
12秒前
英姑的应助被笑点低薯片采纳,获得10
13秒前
夏弱完成签到,获得积分10
14秒前
高级的百香果完成签到,获得积分10
15秒前
April完成签到,获得积分10
15秒前
JamesPei的应助被Alexlovar采纳,获得30
16秒前
16秒前
青山白鸟完成签到 ,获得积分10
17秒前
17秒前
YDB发布了新的文献求助10
17秒前
18秒前
18秒前
充电宝的应助被三十六采纳,获得10
18秒前
D_DAY发布了新的文献求助10
18秒前
科研通AI2S的应助被只因采纳,获得10
19秒前
20秒前
fiveby完成签到 ,获得积分10
20秒前
jean发布了新的文献求助10
21秒前
彭于晏的应助被思恩Shen采纳,获得10
21秒前
Lars发布了新的文献求助10
21秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181839
求助须知:如何正确求助?哪些是违规求助? 9571584
关于积分的说明 21818707
捐赠科研通 7778124
什么是DOI,文献DOI怎么找? 3433524
关于科研通互助平台的介绍 2557710
邀请新用户注册赠送积分活动 2479621